Cargando…

Sensitivity and specificity of PET/CT regarding the detection of lymph node metastases in prostate cancer recurrence

BACKGROUND: The aim of the study is to assess the efficacy of choline PET/CT regarding the detection of lymph node (LN) metastases in recurrent prostate cancer (PCa). METHODS: 49 patients with a biochemical recurrence of PCa (PSA >0.2 ng/ml) were included in the study. All patients were selected...

Descripción completa

Detalles Bibliográficos
Autores principales: Osmonov, Daniar K, Heimann, Diana, Janßen, Isa, Aksenov, Alexey, Kalz, Almut, Juenemann, Klaus Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096858/
https://www.ncbi.nlm.nih.gov/pubmed/25045614
http://dx.doi.org/10.1186/2193-1801-3-340
_version_ 1782326176570671104
author Osmonov, Daniar K
Heimann, Diana
Janßen, Isa
Aksenov, Alexey
Kalz, Almut
Juenemann, Klaus Peter
author_facet Osmonov, Daniar K
Heimann, Diana
Janßen, Isa
Aksenov, Alexey
Kalz, Almut
Juenemann, Klaus Peter
author_sort Osmonov, Daniar K
collection PubMed
description BACKGROUND: The aim of the study is to assess the efficacy of choline PET/CT regarding the detection of lymph node (LN) metastases in recurrent prostate cancer (PCa). METHODS: 49 patients with a biochemical recurrence of PCa (PSA >0.2 ng/ml) were included in the study. All patients were selected for further diagnostics with a choline-PET/CT. All patients underwent salvage extended lymphadenectomy. The PET/CT result and the histological findings were analyzed regarding the specificity and sensitivity and with respect to the localization of the metastases. The detection rate of LN metastases was analyzed with respect to interdependencies between the pre-PET/CT PSA-value as well as the role of prior ADT. RESULTS: 41 out of 49 (83.6%) patients showed positive PET/CT results. Positive LNs were found in 27 out of 49 patients (55.1%). 48.9% of the PET-CT-findings proved true positive, 36.7% were found to be false positive. 8.1% proved true negative and 8.1% false negative. This results in a specificity of 22.7% and a sensitivity of 85.1%. Out of the true positive PET/CT scans, 61.9% were not congruent regarding the localization of positive LNs. In patients with PSA [greater than or equal to] 5 ng/ml, the sensitivity of the PET/CT result was 93.7%, while specificity was 0%. In 24 patients who underwent ADT prior to the PET/CT diagnostics, the sensitivity was 84.6% and specificity 9.0%. CONCLUSIONS: The reliability of PET/CT imaging for detection of LN metastases is limited by a high false-positive rate. The influence of ADT further diminishes the PET/CT reliability. Sensitivity of the PET/CT is highest in patients with a PSA of [greater than or equal to] 5 ng/ml. Based on our results, we propose the following conclusions: 1. There is no well-established diagnostic alternative to Choline-PET/CT Scan. Therefore this method may continue to be performed in patients with BCR. 2. It is not sufficient to remove only those LNs that show up in the PET/CT. 3. Salvage extended lymphadenectomy should follow a predefined template (e.g. the “Kiel template”) and not just the PET/CT scan results.
format Online
Article
Text
id pubmed-4096858
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-40968582014-07-18 Sensitivity and specificity of PET/CT regarding the detection of lymph node metastases in prostate cancer recurrence Osmonov, Daniar K Heimann, Diana Janßen, Isa Aksenov, Alexey Kalz, Almut Juenemann, Klaus Peter Springerplus Research BACKGROUND: The aim of the study is to assess the efficacy of choline PET/CT regarding the detection of lymph node (LN) metastases in recurrent prostate cancer (PCa). METHODS: 49 patients with a biochemical recurrence of PCa (PSA >0.2 ng/ml) were included in the study. All patients were selected for further diagnostics with a choline-PET/CT. All patients underwent salvage extended lymphadenectomy. The PET/CT result and the histological findings were analyzed regarding the specificity and sensitivity and with respect to the localization of the metastases. The detection rate of LN metastases was analyzed with respect to interdependencies between the pre-PET/CT PSA-value as well as the role of prior ADT. RESULTS: 41 out of 49 (83.6%) patients showed positive PET/CT results. Positive LNs were found in 27 out of 49 patients (55.1%). 48.9% of the PET-CT-findings proved true positive, 36.7% were found to be false positive. 8.1% proved true negative and 8.1% false negative. This results in a specificity of 22.7% and a sensitivity of 85.1%. Out of the true positive PET/CT scans, 61.9% were not congruent regarding the localization of positive LNs. In patients with PSA [greater than or equal to] 5 ng/ml, the sensitivity of the PET/CT result was 93.7%, while specificity was 0%. In 24 patients who underwent ADT prior to the PET/CT diagnostics, the sensitivity was 84.6% and specificity 9.0%. CONCLUSIONS: The reliability of PET/CT imaging for detection of LN metastases is limited by a high false-positive rate. The influence of ADT further diminishes the PET/CT reliability. Sensitivity of the PET/CT is highest in patients with a PSA of [greater than or equal to] 5 ng/ml. Based on our results, we propose the following conclusions: 1. There is no well-established diagnostic alternative to Choline-PET/CT Scan. Therefore this method may continue to be performed in patients with BCR. 2. It is not sufficient to remove only those LNs that show up in the PET/CT. 3. Salvage extended lymphadenectomy should follow a predefined template (e.g. the “Kiel template”) and not just the PET/CT scan results. Springer International Publishing 2014-07-04 /pmc/articles/PMC4096858/ /pubmed/25045614 http://dx.doi.org/10.1186/2193-1801-3-340 Text en © Osmonov et al.; licensee Springer. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research
Osmonov, Daniar K
Heimann, Diana
Janßen, Isa
Aksenov, Alexey
Kalz, Almut
Juenemann, Klaus Peter
Sensitivity and specificity of PET/CT regarding the detection of lymph node metastases in prostate cancer recurrence
title Sensitivity and specificity of PET/CT regarding the detection of lymph node metastases in prostate cancer recurrence
title_full Sensitivity and specificity of PET/CT regarding the detection of lymph node metastases in prostate cancer recurrence
title_fullStr Sensitivity and specificity of PET/CT regarding the detection of lymph node metastases in prostate cancer recurrence
title_full_unstemmed Sensitivity and specificity of PET/CT regarding the detection of lymph node metastases in prostate cancer recurrence
title_short Sensitivity and specificity of PET/CT regarding the detection of lymph node metastases in prostate cancer recurrence
title_sort sensitivity and specificity of pet/ct regarding the detection of lymph node metastases in prostate cancer recurrence
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096858/
https://www.ncbi.nlm.nih.gov/pubmed/25045614
http://dx.doi.org/10.1186/2193-1801-3-340
work_keys_str_mv AT osmonovdaniark sensitivityandspecificityofpetctregardingthedetectionoflymphnodemetastasesinprostatecancerrecurrence
AT heimanndiana sensitivityandspecificityofpetctregardingthedetectionoflymphnodemetastasesinprostatecancerrecurrence
AT janßenisa sensitivityandspecificityofpetctregardingthedetectionoflymphnodemetastasesinprostatecancerrecurrence
AT aksenovalexey sensitivityandspecificityofpetctregardingthedetectionoflymphnodemetastasesinprostatecancerrecurrence
AT kalzalmut sensitivityandspecificityofpetctregardingthedetectionoflymphnodemetastasesinprostatecancerrecurrence
AT juenemannklauspeter sensitivityandspecificityofpetctregardingthedetectionoflymphnodemetastasesinprostatecancerrecurrence